Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,160 | 3 | 46.7% |
| Food and Beverage | $3,172 | 112 | 35.6% |
| Travel and Lodging | $1,205 | 3 | 13.5% |
| Education | $374.92 | 5 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $4,539 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,404 | 2 | $0 (2024) |
| ABBVIE INC. | $777.38 | 33 | $0 (2024) |
| GENZYME CORPORATION | $432.73 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $385.35 | 5 | $0 (2024) |
| Dermavant Sciences, Inc. | $207.56 | 12 | $0 (2024) |
| Galderma Laboratories, L.P. | $169.34 | 3 | $0 (2022) |
| Allergan Inc. | $152.92 | 4 | $0 (2017) |
| MERZ NORTH AMERICA, INC. | $147.87 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $123.75 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,881 | 41 | Janssen Biotech, Inc. ($2,757) |
| 2023 | $1,895 | 15 | Janssen Biotech, Inc. ($1,560) |
| 2022 | $513.69 | 10 | GENZYME CORPORATION ($220.71) |
| 2021 | $253.84 | 6 | Galderma Laboratories, L.P. ($90.44) |
| 2020 | $145.23 | 3 | AbbVie Inc. ($108.80) |
| 2019 | $278.07 | 8 | Regeneron Healthcare Solutions, Inc. ($124.80) |
| 2018 | $224.87 | 7 | AbbVie, Inc. ($141.45) |
| 2017 | $720.06 | 33 | AbbVie, Inc. ($201.53) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $148.73 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Dermatology | ||||||
| 10/16/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: Dermatology | ||||||
| 10/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $97.18 | General |
| Category: Immunology | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $1,390.00 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Dermatology | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Immunology | ||||||
| 09/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $666.36 | General |
| Category: Immunology | ||||||
| 09/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $435.95 | General |
| Category: Immunology | ||||||
| 09/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Travel and Lodging | In-kind items and services | $102.30 | General |
| Category: Immunology | ||||||
| 09/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.90 | General |
| Category: Immunology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 09/04/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Dermatology | ||||||
| 08/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: DERMATOLOGY | ||||||
| 08/07/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: Dermatology | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Consulting Fee | Cash or cash equivalent | $1,380.00 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: IMMUNOLOGY | ||||||
| 07/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $80.89 | General |
| Category: Immunology | ||||||
| 07/15/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Dermatology | ||||||
| 07/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 664 | 1,016 | $153,988 | $41,884 |
| 2022 | 11 | 626 | 1,052 | $120,384 | $48,050 |
| 2021 | 9 | 524 | 777 | $84,144 | $39,660 |
| 2020 | 8 | 489 | 771 | $75,406 | $31,348 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 221 | 317 | $69,701 | $16,501 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 68 | $19,690 | $5,310 | 27.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 106 | 141 | $14,984 | $5,107 | 34.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 17 | $8,193 | $3,594 | 43.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 52 | 57 | $10,011 | $3,296 | 32.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 50 | 55 | $8,843 | $1,986 | 22.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 17 | $6,710 | $1,622 | 24.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 24 | $4,853 | $1,248 | 25.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 32 | $3,077 | $923.45 | 30.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,552 | $854.92 | 24.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 25 | $2,169 | $779.70 | 36.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 67 | 247 | $2,206 | $663.10 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 209 | 329 | $44,608 | $19,109 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 82 | $15,548 | $6,796 | 43.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 96 | 131 | $13,921 | $4,922 | 35.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 19 | 19 | $9,157 | $4,111 | 44.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 63 | 75 | $12,059 | $3,976 | 33.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 34 | 41 | $7,201 | $2,790 | 38.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 30 | 31 | $6,268 | $2,187 | 34.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 21 | 31 | $2,689 | $1,148 | 42.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 11 | 11 | $4,341 | $1,035 | 23.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 63 | 275 | $2,456 | $1,013 | 41.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 27 | $2,136 | $961.69 | 45.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 186 | 248 | $31,663 | $16,092 | 50.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 84 | $14,448 | $7,505 | 51.9% |
About Dr. Nananamibia Duffy, M.D
Dr. Nananamibia Duffy, M.D is a Internal Medicine healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700918950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nananamibia Duffy, M.D has received a total of $8,912 in payments from pharmaceutical and medical device companies, with $4,881 received in 2024. These payments were reported across 123 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($4,160).
As a Medicare-enrolled provider, Duffy has provided services to 2,303 Medicare beneficiaries, totaling 3,616 services with total Medicare billing of $160,942. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Rochester, NY
- Active Since 03/12/2007
- Last Updated 09/19/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1700918950
Products in Payments
- TREMFYA (Drug) $4,477
- SPEVIGO (Drug) $1,404
- DUPIXENT (Biological) $670.66
- SKYRIZI (Biological) $434.40
- Humira (Biological) $295.55
- VTAMA (Drug) $207.56
- AKLIEF (Drug) $156.41
- Tremfya (Drug) $149.80
- DUPIXENT (Drug) $118.75
- Bimzelx (Biological) $97.18
- ILUMYA (Biological) $91.35
- Xeomin (Biological) $87.06
- Sotyktu (Drug) $80.89
- XTRAC (Device) $74.09
- TALTZ (Drug) $36.79
- STELARA (Biological) $36.19
- DUPIXENT DUPILUMAB INJECTION (Biological) $28.67
- COSENTYX (Biological) $23.66
- RHOFADE (Drug) $22.56
- INFLECTRA (Biological) $21.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester
Dr. Ben George, M.d, M.D
Internal Medicine — Payments: $729,795
John Kisiel, M.d, M.D
Internal Medicine — Payments: $550,377
Gregory Poland, M.d, M.D
Internal Medicine — Payments: $532,099
Christopher Ritchlin, Md, MD
Internal Medicine — Payments: $512,889
Scott Feitell, D.o, D.O
Internal Medicine — Payments: $471,187
Prashant Kapoor, Md, MD
Internal Medicine — Payments: $403,295